22-45414343-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015653.5(RIBC2):c.151G>T(p.Val51Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000286 in 1,398,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015653.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIBC2 | NM_015653.5 | c.151G>T | p.Val51Phe | missense_variant | Exon 2 of 7 | ENST00000614167.2 | NP_056468.3 | |
RIBC2 | XM_017028766.2 | c.151G>T | p.Val51Phe | missense_variant | Exon 2 of 5 | XP_016884255.1 | ||
RIBC2 | XM_005261524.5 | c.-69G>T | 5_prime_UTR_variant | Exon 2 of 7 | XP_005261581.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000286 AC: 4AN: 1398884Hom.: 0 Cov.: 31 AF XY: 0.00000290 AC XY: 2AN XY: 689976
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.136G>T (p.V46F) alteration is located in exon 2 (coding exon 2) of the RIBC2 gene. This alteration results from a G to T substitution at nucleotide position 136, causing the valine (V) at amino acid position 46 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.